We also discovered a previously unrecognized pathway regulating T‐cell motility, which may provide a mechanistic basis for the role of DPP4 in atherosclerosis and raise the possibility of targeting the noncatalytic function of DPP4 as a therapeutic strategy. This evidence concerns the gene DPP4 and atherosclerosis.